SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9445210
Source:
http://linkedlifedata.com/resource/pubmed/id/9445210
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0016360
,
umls-concept:C0040864
,
umls-concept:C0087111
,
umls-concept:C0242852
,
umls-concept:C1517004
,
umls-concept:C1517572
,
umls-concept:C1656863
pubmed:issue
1
pubmed:dateCreated
1998-2-9
pubmed:abstractText
To determine the efficacy and pharmacokinetics of an intravitreal sustained-release triamcinolone acetonide and 5-fluorouracil (TA/5-FU) codrug in the treatment of experimental proliferative vitreoretinopathy (PVR).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/EYO-11041
,
http://linkedlifedata.com/resource/pubmed/grant/EYO-9106
,
http://linkedlifedata.com/resource/pubmed/grant/P30 EYO5722
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Implants
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Triamcinolone
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0003-9950
pubmed:author
pubmed-author:AshtonPP
,
pubmed-author:DREWJ EJE
,
pubmed-author:HainsworthD PDP
,
pubmed-author:JaffeG JGJ
,
pubmed-author:KhawlyJ AJA
,
pubmed-author:YUH MHM
,
pubmed-author:YangC SCS
pubmed:issnType
Print
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
69-77
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9445210-Animals
,
pubmed-meshheading:9445210-Chromatography, High Pressure Liquid
,
pubmed-meshheading:9445210-Delayed-Action Preparations
,
pubmed-meshheading:9445210-Disease Models, Animal
,
pubmed-meshheading:9445210-Drug Implants
,
pubmed-meshheading:9445210-Drug Therapy, Combination
,
pubmed-meshheading:9445210-Electroretinography
,
pubmed-meshheading:9445210-Fluorouracil
,
pubmed-meshheading:9445210-Glucocorticoids
,
pubmed-meshheading:9445210-Immunosuppressive Agents
,
pubmed-meshheading:9445210-Injections
,
pubmed-meshheading:9445210-Rabbits
,
pubmed-meshheading:9445210-Treatment Outcome
,
pubmed-meshheading:9445210-Triamcinolone
,
pubmed-meshheading:9445210-Vitreoretinopathy, Proliferative
,
pubmed-meshheading:9445210-Vitreous Body
pubmed:year
1998
pubmed:articleTitle
An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.
pubmed:affiliation
Department of Ophthalmology, Duke University, Durham, NC 27710, USA.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't